Skip to main content

Investors

Ulisse Biomed Group is an integrated biotech group with proprietary technologies, developing diagnostic solutions with a focus on public health, distributed diagnostics and molecular innovation.

About Us

We are technology leaders in distribuited and connected diagnostics


Investors

The Ulisse Biomed Group is an integrated biotech group with proprietary technologies, developing diagnostic solutions with a focus on public health, distributed diagnostics and molecular innovation.


06 August, 2025

Updates and announcements

COMMUNICATION OF CONCESSION FOR POR FESR 2021-2027


PROCESS OPTIMIZATION IN THE BIOMEDICAL FIELD.

THE OBJECTIVE OF THE PROJECT IS TO SUPPORT THE COMPANY IN IN THE INNOVATION OF ITS PRODUCTION PROCESSES, ACCOMPANYING THE COMPANY FROM THE DESIGN PHASE UP TO THE FINAL PRODUCTION OF PRODUCTS, BY MEANS OF STRATEGIC INVESTMENTS IN MATERIAL GOODS AND SPECIALIST CONSULTING. IN PARTICULAR, TECHNOLOGICALLY ADVANCED TOOLS HAVE BEEN ACQUIRED TO GUARANTEE HIGH QUALITY STANDARDS AND RAPIDITY IN DEVELOPMENT, IN ADDITION TO THE IMPLEMENTATION OF CUSTOMIZED INFORMATION SOLUTIONS FOR THE AGILE DEVELOPMENT OF NEW DIAGNOSTIC TESTING, IN COMPLIANCE WITH THE STRICT REQUIREMENTS OF ISO 13485.

ALLOWABLE EXPENDITURE. 191.635,00 EURO
CONTRIBUTE PR FESR FVG 76.654,00 EURO
OF WHICH UE 30.661,60 EURO